Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden

APMIS

Volumn 119, Issue 4-5, 2011, Pages 287-295

  Önnberg, Anna ^a   Mölling, Paula ^a   Zimmermann, Johanna ^a   Söderquist, Bo ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CTX M; Escherichia coli; Extended spectrum lactamase; Klebsiella pneumoniae; Sequencing

Indexed keywords

BETA LACTAMASE CTX M; EXTENDED SPECTRUM BETA LACTAMASE;

ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATION; CONTROLLED STUDY; ENDEMIC SPECIES; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENE SEQUENCE; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SWEDEN;

BASE SEQUENCE; BETA-LACTAMASES; DNA PRIMERS; DNA, BACTERIAL; ENDEMIC DISEASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; PHYLOGENY; SWEDEN;

EID: 79954726789     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02730.x     Document Type: Article

References (32)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
2. Coque TM, Baquero F, Cantón R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008;13:pii: 19044.
3. Eisen D, Russell EG, Tymms M, Roper EJ, Grayson ML, Turnidge J. Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol 1995;33:713-7.
4. Gaillot O, Maruéjouls C, Abachin É, Lecuru F, Arlet G, Simonet M, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:1357-60.
5. Lytsy B, Sandegren L, Tano E, Torell E, Andersson DI, Melhus Å. The first major extended-spectrum β-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 2008;116:302-8.
6. Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-59.
7. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
8. Ambler RP. The structure of β-lactamases. Philos Trans R Soc Lond B Biol Sci 1980;289:321-31.
9. Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, et al. Redefining extended-spectrum β-lactamases: balancing science and clinical need. J Antimicrob Chemother 2009;63:1-4.
10. Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006;9:466-75.
11. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-86.
12. Bonnet R. Growing group of extended-spectrum β-lactamases: the CTX-M-enzymes. Antimicrob Agents Chemother 2004;48:1-14.
13. Livermore DM, Cantón R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165-74.
14. Nyberg SD, Österblad M, Hakanen AJ, Huovinen P, Jalava J, the Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand J Infect Dis 2007;39:417-24.
15. Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt-Moller N. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark. APMIS 2008;116:118-24.
16. Fang H, Ataker F, Hedin G, Dornbusch K. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol 2008;46:707-12.
17. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, et al. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 2009;117:526-36.
18. Birkett CI, Ludlam HA, Woodford N, Brown DFJ, Brown NM, Roberts MTM, et al. Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum β-lactamases. J Med Microbiol 2007;56:52-5.
19. Ahmed AM, Nakano H, Shimamoto T. The first characterization of extended-spectrum β-lactamase-producing Salmonella in Japan. J Antimicrob Chemother 2004;54:283-4.
20. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004;48:1249-55.
21. Sundsfjord A, Simonsen GS, Haldorsen BC, Haaheim H, Hjelmevoll SO, Littauer P, et al. Genetic methods for detection of antimicrobial resistance. APMIS 2004;112:815-37.
22. Berglund C, Mölling P, Sjöberg L, Söderquist B. Multilocus sequence typing of methicillin-resistant Staphylococcus aureus from an area of low endemicity by real-time PCR. J Clin Microbiol 2005;43:4448-54.
23. Möllby R, Kühn I, Katouli M. Computerised biochemical fingerprinting - a new tool for typing of bacteria. Rev Med Microbiol 1993;4:231-41.
24. Tullus K, Burman LG, Haeggman S, Hutchinson G, Kühn I. Epidemiologic typing of international collections of Klebsiella spp.: computerized biochemical fingerprinting compared with serotyping, phagetyping and pulsed-field gel electrophoresis. Clin Microbiol Infect 1999;5:184-9.
25. Ansaruzzaman M, Bhuiyan NA, Begum YA, Kühn I, Nair GB, Sack DA, et al. Characterization of enterotoxigenic Escherichia coli from diarrhoeal patients in Bangladesh using phenotyping and genetic profiling. J Med Microbiol 2007;56:217-22.
26. Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson-Liljequist B. Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: description of an outbreak. Scand J Infect Dis 2009;41:410-5.
27. Lewis JS II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007;51:4015-21.
28. Pitout JDD, Church DL, Gregson DB, Chow BL, McCracken M, Mulvey MR, et al. Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary health region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 2007;51:1281-6.
29. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JDD. Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 2008;57:441-8.
30. Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 2007;58:349-55.
31. Hawkey PM. Molecular epidemiology of clinically significant antibiotic resistance genes. Br J Pharmacol 2008;153(Suppl.):S406-13.
32. Peirano G, Pitout JDD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010;35:316-21.